Atara Biotherapeutics appoints Eric Hyllengren as COO, retains CFO role

Atara Biotherapeutics, Inc.

Eric Hyllengren appointed Chief Operating Officer effective Oct 14, 2024, while continuing as CFO.
Salary increased to $520,000 per year in connection with the promotion.
Hyllengren has been CFO since April 2023 and with Atara since 2018.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Eric Hyllengren

Chief Operating Officer

ATRA · Atara Biotherapeutics, Inc.

Effective: 2024-10-14
Filed: October 15, 2024, 7:59 PM ET

On October 14, 2024, the Board of Directors (the “Board”) of Atara Biotherapeutics, Inc. (the “Company”) appointed Eric Hyllengren to serve as the Company’s Chief Operating Officer, in addition to his role as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Eric Hyllengren was appointed as Chief Operating Officer at Atara Biotherapeutics, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On October 14, 2024, the Board of Directors (the “Board”) of Atara Biotherapeutics, Inc. (the “Company”) appointed Eric Hyllengren to serve as the Company’s Chief Operating Officer, in addition to his role as the Company’s Chief Financial Officer.

View on SEC.gov

Atara Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-237582

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.